Clinical Challenges

Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Gammopathy, and Skin Changes (POEMS) Syndrome

Ellen C. Mullen

ONF 2008, 35(5), 763-767. DOI: 10.1188/08.ONF.763-767

Jump to a section

    References

    Laurenti, L., De Matteis, S., Sabatelli, M., Conte, A., Chiusolo, P., Sora, F., et al. (2008). Early diagnosis followed by front-line autologous peripheral blood stem cell transplantation for patients affected by POEMS syndrome. Leukemia Research, 32(8), 1309-1312.
    Matsui, H., Udaka, F., Kubori, T., Oda, M., Nishinaka, M., & Kameyama, M. (2004). POEMS syndrome demonstrating VEGF decrease by ticlopidine. Internal Medicine, 43(11), 1082-1083.
    Nakajima, H., Ishida, S., Furutama, D., Sugino, M., Kimura, F., Yokote, T., et al. (2007). Expression of vascular endothelial growth factor by plasma cells in the sclerotic bone lesions of a patient with POEMS syndrome. Journal of Neurology, 254(4), 531-533.
    Authier, F. J., Belec, L., & Levy, Y. (1996). All transretinoic acid in POEMS syndrome. Therapeutic effect associated with decreased circulating levels of proinflammatory cytokines. Arthritis and Rheumatism, 39(8), 1423-1426.
    Badros, A., Porter, N., & Zimrin, A. (2005). Bevacizumab therapy for POEMS syndrome. Blood, 106(3), 1135.
    Bardwick, P. A., Zvaifler, N. J., Gill, G. N., Newman, D., Greenway, D. L., & Resnick, D. L. (1980). Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes: The POEMS syndrome. Medicine, 59(4), 311-322.
    Chan, J. (2006). POEMS syndrome. Retrieved May 3, 2008, from http://www.emedicine.com/derm/TOPIC771.htm
    Colaco, S., Miller, T., Ruben, B., Fogarty, P., & Fox, L. (2008). IgM-λ paraproteinemia with associated cutaneous lymphoplasmacytic infiltrate in a patient who meets diagnostic criteria for POEMS syndrome. Journal of the American Academy of Dermatology, 58(4), 671-675.
    Dispenzieri, A. (2007). POEMS syndrome. Blood Reviews, 21(6), 285-299.
    Dispenzieri, A., & Gertz, M. (2005). Treatment options for POEMS syndrome. Expert Opinion on Pharmacotherapy, 6(6), 945-953.
    Dispenzieri, A., Kyle, R., Lacy, M., Rajkumar, V., Therneau, T., Larson, D., et al. (2003). POEMS syndrome: Definitions and long-term outcome. Blood, 101(7), 2496-2506.
    Enevoldson, T. P., & Harding, A. E. (1992). Improvement in the POEMS syndrome after administration of tamoxifen. Journal of Neurology, Neurosurgery, and Psychiatry, 55(1), 71-72.
    Gutgemann, I., Stevens, K., Loftus, D., Schmidt-Wolfs, I., & George, J. (2008). VEGF and osteosclerosis in POEMS syndrome. Annals of Hematology, 87(3), 243-245.
    Hyett, J. (2003). What's wrong with this patient? RN, 66(11), 45-48.
    Kyle, R., & Rajkumar, S. (2007). POEMS syndrome (osteosclerotic myeloma). Retrieved April 4, 2008, from http://www.uptodate.com/patients/content/topic.do?topicKey=plasma/7801s
    Rathakrishnan, R., Liu, T., Chen, Y. C., & Ong, B. (2007). POEMS syndrome—A case for more aggressive treatment. Annals of the Academy of Medicine, 36(6), 435-437.
    Saida, K., Kawakami, H., Ohta, M., & Iwamura, K. (1997). Coagulation and vascular abnormalities in Crow-Fukase syndrome. Muscle and Nerve, 20(4), 486-492.
    Samaras, P., Bauer, S., Stenner-Liewen, F., Steiner, R., Zweifel, M., Renner, C., et al. (2007). Treatment of POEMS syndrome with bevacizumab. Haematologica, 92(10), 1438-1439.
    Scarlato, M., Previtali, S., Carpo, M., Pareyson, D., Briani, C., Del Bo, R., et al. (2005). Polyneuropathy in POEMS syndrome. Brain, 128(8), 1911-1920.
    Sinisalo, M., Hietaharju, A., Sauranan, J., & Wirta, O. (2004). Thalidomide in POEMS syndrome: Case report. American Journal of Hematology, 76(1), 66-68.
    Chan, J. (2006). POEMS syndrome. Retrieved May 3, 2008, from http://www.emedicine.com/derm/TOPIC771.htm
    Colaco, S., Miller, T., Ruben, B., Fogarty, P., & Fox, L. (2008). IgM-λ paraproteinemia with associated cutaneous lymphoplasmacytic infiltrate in a patient who meets diagnostic criteria for POEMS syndrome. Journal of the American Academy of Dermatology, 58(4), 671-675.
    Dispenzieri, A. (2007). POEMS syndrome. Blood Reviews, 21(6), 285-299.
    Dispenzieri, A., Kyle, R., Lacy, M., Rajkumar, V., Therneau, T., Larson, D., et al. (2003). POEMS syndrome: Definitions and long-term outcome. Blood, 101(7), 2496-2506.
    Hyett, J. (2003). What's wrong with this patient? RN, 66(11), 45-48.
    Kyle, R., & Rajkumar, S. (2007). POEMS syndrome (osteosclerotic myeloma). Retrieved April 4, 2008, from http://www.uptodate.com/patients/content/topic.do?topicKey=plasma/7801
    Laurenti, L., De Matteis, S., Sabatelli, M., Conte, A., Chiusolo, P., Sora, F., et al. (2008). Early diagnosis followed by front-line autologous peripheral blood stem cell transplantation for patients affected by POEMS syndrome. Leukemia Research, 32(8), 1309-1312.
    Rathakrishnan, R., Liu, T., Chen, Y. C., & Ong, B. (2007). POEMS syndrome—A case for more aggressive treatment. Annals of the Academy of Medicine, 36(6), 435-437.
    Weimer, T., Norton, A., & Gutmann, L. (2006). Glomeruloid hemangioma: A marker for POEMS. Neurology, 66(3), 453-454.
    Arimura, K. (1999). Increased vascular endothelial growth factor (VEGF) is causative in Crow-Fukase syndrome. Rinsho Shinkeigaku Clinical Neurology, 39(1), 84-85.